For condition: ECZEMA - ATOPIC DERMATITIS
Eczema Study (12 Months)
Study Summary
Who Can Participate?
Adults aged 18 to less than 75 with moderate to severe eczema (atopic dermatitis) may participate.
Inclusion Criteria
- have had eczema for at least 1 year
- have had inadequate response to topical prescription therapies
- the eczema covering their body is equal to about 10 of your palm prints (about 10% of their body)
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating eczema (19 visits)
- Will receive either an investigative injection treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- 68 weeks after a screening period of up to 5 weeks
For more information about this trial, please visit ClinicalTrials.gov
